Inferior vena cava involvement in renal cell carcinoma: comparison of survival rates between patients with thrombus and infiltration

Scandinavian Journal of Urology and Nephrology
Vahudin ZugorGünter E Schott

Abstract

In 4-10% of cases of renal cell carcinoma (RCC), involvement of the inferior vena cava (IVC) is present. IVC involvement may be due to either a pure thrombus or tumor extension. This study indicates that there is no significant difference in survival rates between patients with thrombus and those with infiltration of the IVC. The records of 84 patients who presented to our institution with RCC and IVC involvement and received surgical treatment between July 1973 and June 2006 were examined. The postoperative observation period was 120 months. Statistical analysis was performed using the Kaplan-Meier method and the log-rank test. Sixty-one patients demonstrated thrombus involvement of the IVC, while the remaining 23 exhibited infiltration. Over the observation period, an average survival time of 64.0 months was observed. The median survival time was 35.2 months. No significant difference in survival rates was observed between patients with thrombus and those with malignant infiltration of the IVC. It is stated in the contemporary literature that IVC infiltration is an important prognostic factor in cases of RCC. This study indicates that there is no significant difference in survival rates between patients with thrombus and thos...Continue Reading

References

Jan 1, 1991·The Journal of Urology·P A HatcherJ E Robertson
Nov 1, 1982·The Journal of Urology·R J CherrieJ B deKernion
Feb 1, 1980·The Journal of Urology·R V ClaymanE E Fraley
Aug 1, 1994·American Journal of Surgery·D J SwierzewskiJ A Libertino
Feb 1, 1997·The Journal of Urology·J A Johnsen, S Hellsten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.